0.29Open0.44Pre Close13 Volume136 Open Interest81.00Strike Price111.00Turnover265.58%IV0.98%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.1109Delta0.3373Gamma2674.67Leverage Ratio-20.7228Theta0.0000Rho296.70Eff Leverage0.0004Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet